Restaurant, Breakfast Area No. 2

The Russian Government has allocated nearly RUB 660 billion for investment in the healthcare industry over the next two years. The transition to a new healthcare system will include a number of fundamental changes, including the move from gross estimate financing to payment for services actually supplied; state procurement of medical services open to private enterprises; concessionary projects in healthcare models already in place; improved business management approaches for running medical institutions; and the introduction of a compulsory medical insurance system among other initiatives.

1) What are the major changes we can expect in Russian healthcare over the coming five to seven years? What is the budgetary impact for this approach? What are the key cost control mechanisms in the new system?
2) How can modern management methodologies lead to greater efficiency in Russian heath care?
3) How can international businesses and finance bodies participate and benefit from these changes?

Yuri Krestinsky , Director, Institute of Public Health

Oleg Atkov , Vice-President, Russian Railways
Rita Bobro , Managing Director, Merck KGaA
Hakan Björklund , CEO, Nycomed
Alexey Repik , President, Delovaya Rossiya (Business Russia)
Alexey Repik , President, Delovaya Rossiya (Business Russia)
John Conroy , Head of Global Strategic Initiatives, Baker & McKenzie
Mark Kurtser , Chairman of the Board of Directors, MD Medical Group Investments
Valentina Matviyenko , Governor of St. Petersburg
Vikram Singh Punia , Chairman of the Board of Directors, Pharmasyntez JSC
Alexey Repik , President, Delovaya Rossiya (Business Russia)
Steve Rusckowski , Executive Vice-President, Royal Philips Electronics; Chief Executive Officer, Philips Healthcare
Veronika Skvortsova , Minister of Healthcare of the Russian Federation
Joseph Jimenez , Chief Executive Officer, Novartis AG
Vladimir Shipkov , Executive Director, Association of International Pharmaceutical Manufacturers (AIPM)
Paul Stoffels , Company Group Chairman, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Andrei Yurin , Deputy Minister of Healthcare of the Russian Federation
Lev Jakobson , First Vice Rector, National Research University Higher School of Economics